RxDoctor Payments Data

Abigail Marx, PA

Physician Assistant · North Charleston, SCNPI 1013337708

Payments from drug & device makers

$4,085in general payments, 2019–2025

Across 170 payments — averaging $24.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Amgen$749
  • Collegium Pharmaceutical, Inc.$231
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$186
  • Radius Health, Inc.$178
  • AbbVie$172
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$4,085100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,085 in reported general payments places this provider in the 85th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$11,012
Medicare patients
74
Services billed
151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide13$30,718
OxycontinOxycodone Hcl38$18,644
Xtampza ErOxycodone Myristate42$17,599
BelbucaBuprenorphine Hcl25$14,602
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen563$13,488
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen349$9,380
Buprenorphine54$9,334
MovantikNaloxegol Oxalate16$7,402
Diclofenac Sodium71$6,101
Morphine Sulfate ErMorphine Sulfate207$5,580
Lidocaine46$4,792
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl26$4,763
Pregabalin190$4,450
Fentanyl32$3,559
Gabapentin254$3,031

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$231$32,20267 claims
Radius Health, Inc.Tymlos$178$30,71813 claims
Redhill Biopharma Inc.Movantik$55$7,40216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in North Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →